在癌症患者中,大麻使用与抑郁症的关联
Shulu Hu1, Anqi Lin1, Peng Luo1
1Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou 510000, Guangdong, China.
Preventive medicine reports
|July 17, 2023
概括
使用大麻的癌症患者患抑郁症的风险更高. 这项研究发现,目前的大麻使用与癌症患者的抑郁症增加有显著的相关性,特别是在特定的亚组中.
科学领域:
- 在瘤学瘤学.
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
背景情况:
- 在癌症患者中,大麻的使用正在增加.
- 在这个人群中,与大麻使用相关的心理健康风险,特别是抑郁症,需要进行彻底的评估.
研究的目的:
- 分析大麻使用与癌症患者抑郁症之间的关联.
- 确定与大麻使用相关的抑郁症风险较高的癌症患者的特定亚组.
主要方法:
- 利用了来自国家健康和营养检查调查 (2005-2018) 的数据.
- 包括22,181名受访者,其中893人被诊断患有癌症.
- 使用多变量逻辑回归来评估大麻使用与抑郁症之间的相关性.
主要成果:
- 在癌症患者当前使用大麻和抑郁症风险增加之间发现了显著的正相关性 (OR = 2.135,p = 0.009).
- 分层分析显示,女性癌症患者,有可卡因使用史的患者和17岁后开始使用大麻的患者的抑郁风险增加.
结论:
- 癌症患者使用大麻与更高的抑郁症风险有关.
- 在癌症患者中,目前的大麻使用者更有可能经历抑郁症,突出需要临床关注.
更多相关视频
相关概念视频
Psychoneuroimmunology: Diabetes and Cancer
49
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
49
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
323
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
323
Depression: Overview
281
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
281
Stress and Mental Health
184
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Individuals with depression often experience challenges in both their personal and professional...
184
Stress Prevention and Stress Management Techniques IV
49
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
49
Long-term Depression
31.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
31.0K


